• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性人类催乳素而非外源性人类催乳素可诱导雌激素受体α和催乳素受体表达,并增强乳腺癌细胞中的雌激素反应性。

Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.

作者信息

Gutzman Jennifer H, Miller Kristin K, Schuler Linda A

机构信息

Department of Comparative Biosciences, 2015 Linden Drive, University of Wisconsin-Madison, Madison, WI 53706, USA.

出版信息

J Steroid Biochem Mol Biol. 2004 Jan;88(1):69-77. doi: 10.1016/j.jsbmb.2003.10.008.

DOI:10.1016/j.jsbmb.2003.10.008
PMID:15026085
Abstract

Prolactin (PRL) and estrogen act synergistically to increase mammary gland growth, development, and differentiation. Based on their roles in the normal gland, these hormones have been studied to determine their interactions in the development and progression of breast cancer. However, most studies have evaluated only endocrine PRL and did not take into account the recent discovery that PRL is synthesized by human mammary cells, permitting autocrine/paracrine activity. To examine the effects of this endogenous PRL, we engineered MCF7 cells to inducibly overexpress human prolactin (hPRL). Using this Tet-On MCF7hPRL cell line, we studied effects on cell growth, PRLR, ER alpha, and PgR levels, and estrogen target genes. Induced endogenous hPRL, but not exogenous hPRL, increased ER alpha levels as well as estrogen responsiveness in these cells, suggesting that effects on breast cancer development and progression by estrogen may be amplified by cross-regulation of ER alpha levels by endogenous hPRL. The long PRLR isoform was also upregulated by endogenous, but not exogenous PRL. This model will allow investigation of endogenous hPRL in mammary epithelial cells and will enable further dissection of PRL effects on other hormone signaling pathways to determine the role of PRL in breast cancer.

摘要

催乳素(PRL)和雌激素协同作用,促进乳腺生长、发育和分化。基于它们在正常腺体中的作用,人们对这些激素进行了研究,以确定它们在乳腺癌发生和发展过程中的相互作用。然而,大多数研究仅评估了内分泌型PRL,并未考虑到最近发现的人乳腺细胞能合成PRL,从而产生自分泌/旁分泌活性这一情况。为了研究这种内源性PRL的作用,我们构建了可诱导性过表达人催乳素(hPRL)的MCF7细胞。利用这种Tet-On MCF7hPRL细胞系,我们研究了其对细胞生长、PRLR、雌激素受体α(ERα)、孕激素受体(PgR)水平以及雌激素靶基因的影响。诱导产生的内源性hPRL而非外源性hPRL,增加了这些细胞中的ERα水平以及雌激素反应性,这表明内源性hPRL通过对ERα水平的交叉调节,可能会放大雌激素对乳腺癌发生和发展的影响。长型PRLR异构体也受到内源性PRL而非外源性PRL的上调。该模型将有助于研究乳腺上皮细胞中的内源性hPRL,并能进一步剖析PRL对其他激素信号通路的影响,以确定PRL在乳腺癌中的作用。

相似文献

1
Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.内源性人类催乳素而非外源性人类催乳素可诱导雌激素受体α和催乳素受体表达,并增强乳腺癌细胞中的雌激素反应性。
J Steroid Biochem Mol Biol. 2004 Jan;88(1):69-77. doi: 10.1016/j.jsbmb.2003.10.008.
2
Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.人催乳素(hPRL)拮抗剂可抑制参与乳腺癌细胞增殖的hPRL激活的信号通路。
Oncogene. 2000 Sep 28;19(41):4695-705. doi: 10.1038/sj.onc.1203846.
3
Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells.催乳素和雌激素协同调节乳腺癌细胞的基因表达和增殖。
Endocr Relat Cancer. 2010 Aug 16;17(3):809-22. doi: 10.1677/ERC-09-0326. Print 2010 Sep.
4
Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells.雌激素通过激活蛋白1(AP1)和雌激素反应元件,刺激T47D人乳腺癌细胞中人类催乳素远端启动子的转录。
Mol Cell Endocrinol. 2008 Jan 16;281(1-2):9-18. doi: 10.1016/j.mce.2007.10.004. Epub 2007 Oct 13.
5
Differences in prolactin receptor (PRLR) in mouse and human fallopian tubes: evidence for multiple regulatory mechanisms controlling PRLR isoform expression in mice.小鼠与人输卵管中催乳素受体(PRLR)的差异:控制小鼠PRLR亚型表达的多种调节机制的证据
Biol Reprod. 2008 Oct;79(4):748-57. doi: 10.1095/biolreprod.108.070003. Epub 2008 Jul 2.
6
Re-evaluation of the prolactin receptor expression in human breast cancer.人乳腺癌中催乳素受体表达的重新评估
J Endocrinol. 2009 Apr;201(1):115-28. doi: 10.1677/JOE-08-0479. Epub 2009 Jan 19.
7
Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.催乳素在分化中的小鼠乳腺中的局部过表达会导致功能缺陷和良性病变,但不会引发癌症。
J Endocrinol. 2006 Aug;190(2):271-85. doi: 10.1677/joe.1.06829.
8
The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.催乳素受体介导 HOXA1 刺激的乳腺癌细胞致癌性。
Int J Oncol. 2012 Dec;41(6):2285-95. doi: 10.3892/ijo.2012.1660. Epub 2012 Oct 15.
9
Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.雌激素受体β1的可诱导上调影响MCF7人乳腺癌细胞中的雌激素和他莫昔芬反应性。
J Mol Endocrinol. 2005 Apr;34(2):553-66. doi: 10.1677/jme.1.01688.
10
Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin.雌激素、孕酮和催乳素对猪催乳素受体表达的组织特异性调节
J Endocrinol. 2009 Jul;202(1):153-66. doi: 10.1677/JOE-08-0486. Epub 2009 Apr 28.

引用本文的文献

1
Impact of prolactin treatment on enhancing the cellular responses of MCF7 breast cancer cells to tamoxifen treatment.催乳素治疗对增强MCF7乳腺癌细胞对他莫昔芬治疗的细胞反应的影响。
Discov Oncol. 2024 Dec 18;15(1):797. doi: 10.1007/s12672-024-01701-x.
2
Plasma prolactin and postmenopausal breast cancer risk: a pooled analysis of four prospective cohort studies.血浆催乳素与绝经后乳腺癌风险:四项前瞻性队列研究的汇总分析。
Breast Cancer Res. 2024 Nov 26;26(1):169. doi: 10.1186/s13058-024-01922-6.
3
Prolactin-activated PAK1 potentiates estrogen response to breast cancer cell epithelial-mesenchymal transition, migration and invasion.
催乳素激活的PAK1增强雌激素对乳腺癌细胞上皮-间质转化、迁移和侵袭的反应。
MicroPubl Biol. 2024 Jun 11;2024. doi: 10.17912/micropub.biology.001195. eCollection 2024.
4
The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer.针对 PRLR 的免疫毒素可提高他莫昔芬敏感性,并增强乳腺癌化疗疗效。
J Exp Clin Cancer Res. 2024 Jun 20;43(1):173. doi: 10.1186/s13046-024-03099-4.
5
Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma.干细胞相关特征有助于预测卵巢浆液性囊腺癌的诊断和预后。
Stem Cells Int. 2023 Apr 30;2023:4500561. doi: 10.1155/2023/4500561. eCollection 2023.
6
Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness.催乳素受体基因转录控制,与乳腺癌耐药性和侵袭性相关的调节方式。
Front Endocrinol (Lausanne). 2022 Sep 15;13:949396. doi: 10.3389/fendo.2022.949396. eCollection 2022.
7
Prolactin: The Third Hormone in Breast Cancer.催乳素:乳腺癌的第三激素。
Front Endocrinol (Lausanne). 2022 Jun 16;13:910978. doi: 10.3389/fendo.2022.910978. eCollection 2022.
8
Medicinal Mushroom Imai Extracts Improve Mammary Gland Differentiation in Lactating Rats via Regulating Protein Expression.药用蘑菇今井提取物通过调节蛋白质表达改善泌乳大鼠的乳腺分化。
Evid Based Complement Alternat Med. 2022 Jun 18;2022:5762847. doi: 10.1155/2022/5762847. eCollection 2022.
9
Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer.乳腺癌中泌乳素受体(PRLR)与表皮生长因子受体(EGFR)/人表皮生长因子受体2(HER2)信号通路之间的相互作用
Cancers (Basel). 2021 Sep 18;13(18):4685. doi: 10.3390/cancers13184685.
10
Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.决定 ESR1 转录调控的内在和外在因素。
Horm Cancer. 2020 Aug;11(3-4):129-147. doi: 10.1007/s12672-020-00388-0. Epub 2020 Jun 26.